ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,950.90
0.18%
S&P ASX All Technology
3,534.00
1.10%
Brent Oil
72.455
-0.10%
US Dollar vs AUD
1.59023
-0.05%
Bitcoin
86,432.91
-1.24%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Omega Therapeutics Inc (OMGA) Share Price

Omega Therapeutics Inc

Omega Therapeutics Inc (OMGA)

Omega Pacific Resources Inc
0.1426
0.00
(0.00%)
Closed 25 March 7:00AM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.1426
Bid
0.1111
Offer
0.1158
Volume
-
0.00 Day's Range 0.00
0.0953 52 Week Range 3.77
Market Cap
7.895M
Previous Close
0.1426
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
9,565,537
Shares Outstanding
55,366,213
Dividend Yield
-
PE Ratio
-0.08
Earnings Per Share (EPS)
-1.76
Revenue
3.09M
Net Profit
-97.43M

About Omega Therapeutics Inc

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to trans... Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.omegatherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Omega Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker OMGA. The last closing price for Omega Therapeutics was US$0.14. Over the last year, Omega Therapeutics shares have traded in a share price range of US$ 0.0953 to US$ 3.77.

Omega Therapeutics currently has 55,366,213 shares in issue. The market capitalisation of Omega Therapeutics is US$7.90 million. Omega Therapeutics has a price to earnings ratio (PE ratio) of -0.08.

Ask ADVFN Intelligence (AI)

OMGA Latest News

More News

Form POS AM - Post-Effective amendments for registration statement
Edgar (US Regulatory)
22 March 2025
OMGA (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
25 February 2025
OMGA (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
15 February 2025
OMGA (0.00%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
05 February 2025
OMGA (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
04 February 2025
OMGA (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
29 January 2025
OMGA (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
18 January 2025
OMGA (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
11 January 2025
OMGA (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.14260.14260.142600CS
4-0.0234-14.09638554220.1660.16650.14122455620.1426CS
12-0.6753-82.56510575870.81790.960.095395655370.20708908CS
26-1.1874-89.27819548871.331.690.095344767180.23805817CS
52-3.2474-95.79351032453.393.770.095323838940.38450243CS
156-7.1074-98.03310344837.2511.980.095310466591.46615876CS
260-21.9574-99.354751131222.131.410.09538807841.80877475CS

OMGA - Frequently Asked Questions (FAQ)

What is the current Omega Therapeutics share price?
The current share price of Omega Therapeutics is US$ 0.1426
How many Omega Therapeutics shares are in issue?
Omega Therapeutics has 55,366,213 shares in issue
What is the market cap of Omega Therapeutics?
The market capitalisation of Omega Therapeutics is USD 7.9M
What is the 1 year trading range for Omega Therapeutics share price?
Omega Therapeutics has traded in the range of US$ 0.0953 to US$ 3.77 during the past year
What is the PE ratio of Omega Therapeutics?
The price to earnings ratio of Omega Therapeutics is -0.08
What is the cash to sales ratio of Omega Therapeutics?
The cash to sales ratio of Omega Therapeutics is 2.5
What is the reporting currency for Omega Therapeutics?
Omega Therapeutics reports financial results in USD
What is the latest annual turnover for Omega Therapeutics?
The latest annual turnover of Omega Therapeutics is USD 3.09M
What is the latest annual profit for Omega Therapeutics?
The latest annual profit of Omega Therapeutics is USD -97.43M
What is the registered address of Omega Therapeutics?
The registered address for Omega Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Omega Therapeutics website address?
The website address for Omega Therapeutics is www.omegatherapeutics.com
Which industry sector does Omega Therapeutics operate in?
Omega Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLGOMicroAlgo Inc
US$ 13.99
(455.16%)
304.72M
IMTEIntergrated Media Technology Ltd
US$ 2.0601
(281.57%)
108.14M
VVPRVivoPower International PLC
US$ 3.21
(148.84%)
64.05M
TRSGTungray Technologies Inc
US$ 2.05
(100.98%)
2.73M
CAPSCapstone Holding Corp
US$ 2.6929
(56.56%)
13.6M
WLGSWang and Lee Group Inc
US$ 0.76
(-85.30%)
25.19M
ME23andMe Holding Company
US$ 0.732
(-59.11%)
6.97M
HTCOHigh Trend International Group
US$ 1.0095
(-46.30%)
719.81k
RNAZTransCode Therapeutics Inc
US$ 0.6821
(-39.10%)
17.31M
YHCLQR House Inc
US$ 0.2625
(-34.38%)
30.24M
MLGOMicroAlgo Inc
US$ 13.99
(455.16%)
304.72M
NVDANVIDIA Corporation
US$ 121.41
(3.15%)
228.79M
DMNDamon Inc
US$ 0.04
(7.24%)
227.14M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 11.17
(23.56%)
217.49M
TSLATesla Inc
US$ 278.39
(11.93%)
169.05M

Discussion

View Full Feed
jesster64 jesster64 6 minutes ago
"Many are feeling the same as you and I do not blame anyone for this as the time for patient access to this treatment is long overdue. The time for management to ante up with bridge loans repayable with cash plus 12% interest or shares priced 3X current price with payment due at 1 year, or similar t
NWBO
Tahoe2468 Tahoe2468 10 minutes ago
Once again if this was tradeable on Robinhood we would be at over .25 today got to get that fixed.... 
KRTL
Steady_T Steady_T 10 minutes ago
Actually what Missling said was they applied to the EU first because it takes longer. What he hasn't said is when Anavex intends to apply to the FDA.

If Anavex were to get an application into the FDA in the next month there is good chance both applications would be rules upon about th
AVXL
wadegarret wadegarret 10 minutes ago
Hweb- KINS said in their CC, that they hope to expand business

into New England. Thing is, with Adjusted fully diluted eps upped to $1.95 avg for 2025, and positive comments about their expectations that growth will continue, I think the stock should be at $20 to $22. I mean to sel
Howeeme Howeeme 12 minutes ago
Looks like wasn’t Enhanze but Pegph20.
HALO
potofgold potofgold 12 minutes ago
Ooops! Friday. The 21st was a Friday. Had it stuck in my head that it was some other day.
KGKG
janice shell janice shell 12 minutes ago
LOLOL!! It wasn't my only weird flight... But you know, back then, other passengers weren't problematic.

Well, unless they were hijackers.
Zorax Zorax 13 minutes ago
For whatever they're brain damaged reasons, it sounds like the administration wanted people to hack their war plans. Pukey anyone? And heghog sounded like he was playing a video game.. "c'mon we're ready, lets do this".

The Trump Administration used a third party app that could be
BREAKER098 BREAKER098 14 minutes ago
Glen Bradford’s Reddit history…eww

https://www.reddit.com/user/TheSerpent/submitted/

GB you are troubled sir. Those posts going back 15 years, the girls, the job firings…seriously, and I do mean this, you should probably get some help.

DISCREDITED.
FNMA
PennyWorld PennyWorld 14 minutes ago
Oh man. Just checking in. I was long this play a couple of years ago. Glad I got out. They did a devastating R/S a few months ago, and I suspect they will be doing another one shortly to generate cash. I thought they had a good product. But when I emailed them and asked them how can they stop someon
SOBR
Howeeme Howeeme 14 minutes ago
https://www.prnewswire.com/news-releases/first-patient-dosed-in-clinical-trial-of-halozyme-investigational-drug-pegph20-in-combination-with-merck-immuno-oncology-drug-keytruda-300173008.html
HALO
Scamdestroyer Scamdestroyer 16 minutes ago
Just checking on old faithful and can't believe it is down again! Such a groundbreaking company and it trades at 2 measly pennies! And there are many many many gold backed coins, the difference is they actually have audited gold backing! I'm still waiting for the gold storage pictures that we were t
AABB
stervc stervc 17 minutes ago
TWOH Resumes Trading Following Filing of Meeting Materials: https://www.otcmarkets.com/stock/TWOH/news/story?e&id=3184706
TWOH
littlejohn littlejohn 18 minutes ago
PLTR insider sellers are making out like bandits

on the Astronomical share price...

CEO is a smart seller...

https://finance.yahoo.com/news/heres-the-whopping-amount-of-stock-palantir-ceo-alex-karp-has-dumped-142212250.html

President is a s
PLTR
stervc stervc 18 minutes ago
TWOH Resumes Trading Following Filing of Meeting Materials: https://www.otcmarkets.com/stock/TWOH/news/story?e&id=3184706
TWOH
Mr. Dragon Mr. Dragon 19 minutes ago
Eight months left in the year. Those eight months are when the product will be on the market.
NIO
karmakaziXpert karmakaziXpert 20 minutes ago
Captain scam pumper playing the victim. LOL

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140867030

What a clown this guy has been with his nonsense since 2018.

Same Jimmy playing fake attorney during a threatening communication was pump
SNPW
stervc stervc 20 minutes ago
TWOH Resumes Trading Following Filing of Meeting Materials: https://www.otcmarkets.com/stock/TWOH/news/story?e&id=3184706
TWOH
Babubd Babubd 22 minutes ago
Very exciting times ahead for all of us longs for sure!!
ZHUD
3331 3331 23 minutes ago
BIEL should emphasize the Actipatch battery life more - as a key advantage (in its marketing) - 20 times the $329 Assisi Loop battery, 12 times the $100 Firefly battery, etc. Mark Cuban said the $48 monthly (60 hours of treatment) recurring charge (which is actually $100 according to the website) fo
BIEL
BREAKER098 BREAKER098 23 minutes ago
eom
FNMA
BREAKER098 BREAKER098 23 minutes ago
I’m telling you I don’t know the details because I haven’t looked into it - by design. And sorry to burst your bubble, but I don’t read A LOT of people’s posts. Goodluck with the derivative claims…you’ve found the one speculative set of investments that takes longer than the twins. Truly, Goodlu
FNMA
getmenews getmenews 24 minutes ago
Usually, 99% of the time, when I buy any actual physical shares, it goes down, 99% of the time...

"Lets see what happens this time"...

I'm moving over to track the NDX, this is my last post on this board...

https://investorshub.advfn.com/boards/read_msg.
NDX

Your Recent History

NASDAQ
OMGA
Omega Therapeutics
Delayed Upgrade Clock
ADVFN Logo
Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads